The Role of Aspiration Biopsy in Following Patients Treated With Chemotherapy and Radiation

  • S. Brosman
Part of the NATO Advanced Science Institutes Series book series (NSSA, volume 53)


The value of fine needle aspiration biopsy (FNA) in the diagnosis of prostate cancer has been confirmed repeatedly from numerous studies (1,2). The technique has a high degree of efficiency in that the sensitivity (true positive) and specificity (true negative) correlate well with the standard needle biopsy. The FNA is not recommended as a general screening test for prostate cancer but to help establish the diagnosis in patients whose prostates are suspicious for carcinoma. An additional use of the test may be to help determine response to therapy.


Prostate Cancer Fine Needle Aspiration External Beam Irradiation Aspiration Biopsy Fine Needle Aspiration Biopsy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    P.L. Esposti, Transrectal aspiration biopsy of the prostate with Franzen’s instrument, in: “Bladder tumors and other topics in Urological Oncology,” M. Pavone-Macaluso, P.H. Smith, and F. Edsmyr, eds., Plenum Press, London and New York (1980), p. 459CrossRefGoogle Scholar
  2. 2.
    B.P. Lin, W.E. Davies, and P.A. Harmata, Prostatic aspiration cytology, Pathology 11: 607 (1979).PubMedCrossRefGoogle Scholar
  3. 3.
    P.L. Esposti, Cytologic malignancy grading of prostatic carcinoma by transrectal aspiration biopsy, Scan. J. Urol. Nephrol. 5: 199 (1971).CrossRefGoogle Scholar
  4. 4.
    C. Voeth, M. Drosse, and G. Steur, Cytologic grading of prostatic carcinoma, Urologe 17: 367 (1978).PubMedGoogle Scholar
  5. 5.
    F. Paul, E. Schmidt, and R. Kerr, The prognostic significance of cytologic differentiation grades of estrogen-treated prostatic carcinoma. Follow-up of 496 patients treated with estrogen for 5 years, Urologe 17: 377 (1978).Google Scholar
  6. 6.
    W. Leistenschneider and R. Nagel, Cytologic grading of regression in conservatively treated prostate carcinoma and its prognostic significance, Aktuel Urol. 11: 263 (1980).CrossRefGoogle Scholar
  7. 7.
    K.H. Kurth, J.E. Altwein, D. Skoluda, and R. Hohenfellner, Follow-up of irradiated prostatic carcinoma by aspiration biopsy, J. Urol. 117: 615 (1977).PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1983

Authors and Affiliations

  • S. Brosman
    • 1
  1. 1.Bay Urologic Medical GroupSanta MonicaUSA

Personalised recommendations